Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline as Adjunct in Major Depressive Disorder
NCT02263872Phase 4Completed
- Sponsor
- Pakistan Institute of Living and Learning
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Minocycline + TAU with Placebo + TAU (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 12 weeks. Started Oct 2014; status: completed.
02
Drugs
minocycline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02263872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263872.